Drug Designing: Open Access

Drug Designing: Open Access
Open Access

ISSN: 2169-0138

+441414719275

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Editorial Board

Tuo Deng
Editor-in-Chief
Center for Bioenergetics, Houston Methodist Research Institute
Houston, Texas, USA

Gjumrakch Aliev
Professor of Cardiovascular, Neuropathology and Gerontology
University of Atlanta, USA

Fredrik Bjorkling
Professor, Faculty of Health and Medical Sciences, Department of Drug Design and Pharmacology
University of Copenhagen, Denmark

Submit Manuscript

Journal Impact Factor 5.5*
Submit manuscript at www.scholarscentral.org/submission/drug-designing-open-access.html or send as an e-mail attachment to the Editorial Office at [email protected]

About the Journal

Index Copernicus Value: 66.5

The Journal, Drug Designing: Open Access publishes the highest quality scientific articles amalgamating broad range of fields including molecular modeling, clinical research and drug discovery and delivery.

The journal focuses on all fields of drug design including drug discovery, drug design by rational approach, target-based design, drug synthesis, drug metabolism, structure-based drug design, molecular modeling, ligand-based interaction, development of the generic drug, in silico chemoinformatics and bioinformatics technologies, receptor agonist/antagonist, protease substrate/inhibitor, peptidomimetic, Quality by design, Design for reliability in drug development, Design for traditional Chinese medicine clinical trials, Bayesian sequential design for multi-regional design, Design and analysis for target clinical trials, Design and analysis for diagnostic procedures, Adaptive design for early clinical development, Design for biosimilar studies, Design for bioassay development and validation, Design for statistical genetics, Design for assessment of drug to drug interaction, Design for bridging studies, Design for stability analysis, etc.

This scientific journal includes a wide range of fields in its discipline to create a platform for the authors to make their contribution towards the journal and the editorial office at Longdom Publishing promises a peer review process for the submitted manuscripts to maintain the quality of free journals. The jounal is among the best open access journals and aims to publish most complete and reliable source of information on the discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc. in all areas of the field.

Article published in drug designing journal are freely available online without any restrictions or any other subscriptions to the researchers worldwide. The journal is using Editorial Tracking System for quality in peer review process.

Drug designing journals have been showing tremendous citations and articles focusing the most advanced research trends in the field of drug discovery, medicinal chemistry, Drug Design tools, protein engineering, bioinformatics.
Editorial Manager is an online manuscript submission, review and tracking systems. Review processing is performed by the editorial board members of Drug Designing: Open Access or outside experts; at least two independent reviewer’s approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.

Journal Highlights

Current Issue Highlights

Top